Neurocrine Biosciences (NBIX) Reports Q3 Loss of $0.13
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $138.40 -0.39%
Revenue Growth %: +30.8%
Financial Fact:
Net income (loss): -36.89M
Today's EPS Names:
OCCI, IPX, ALZN, More
Revenue Growth %: +30.8%
Financial Fact:
Net income (loss): -36.89M
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of ($0.13), versus ($0.43) reported last year.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
